Wilder, I've listened to the CC several times & imo they seem as bullish as the law allows. Repeated reference to EADO & ASCO as well. I've felt the EADO Congress was the most intriguing with the Roche collaboration extremely promising, based on previous results.If the Phase 3 Melanoma goes well that would bring in some bucks. How will we get results from Rigas' updates on Wed.? Will they accompany them with a PR or will we have to find out ourselves? Thanks.
"...a PR or will we have to find out ourselves?"
As these are not likely to be pivotal results, I really don't expect a PR. Peter lamb specifically mentioned this presentation in the CC... Unless - the results are so compelling as to qualify for a filing as breakthrough therapy. Should that be the case, I'd expect a PR and a material event filing...
I really don't spend a great deal of time in dermato-oncology sites, but they probably have a journal. If not, I'd expect to see an advanced online ePub in the EJC, the BJC, or the Annals of Oncology...but only if new results are made available. Lithuania is a bit off the beaten path, oncologically speaking.